NT-40 * Interim Analysis of the EF-14 Trial: A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients with Newly Diagnosed GBM
Year: 2014
Type: conference-abstract
Source: Neuro-Oncology
Authors: R. Stupp, E. Wong, C. Scott, S. Taillibert, A. Kanner, S. Kesari, Z. Ram, on behalf of the EF
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2110097008